Bedaquiline Fumarate and TheraCys
Determining the interaction of Bedaquiline Fumarate and TheraCys and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.CONTRAINDICATED: Antituberculosis drugs may interfere with the anti-tumor activity of intravesical BCG, which contains a live, attenuated strain of Mycobacterium bovis. Available data suggest that intravesical BCG may be sensitive to most antibiotics, particularly those that are routinely used in the treatment of tuberculosis such as streptomycin, para-aminosalicylic acid (PAS), isoniazid (INH), rifampin, and ethambutol. It is reportedly not sensitive to pyrazinamide or cycloserine. Regardless of clinical susceptibility data, however, most antibacterials may still interfere with BCG in the bladder due to their high urinary recovery. MANAGEMENT: Concomitant use of antituberculosis drugs is considered contraindicated during intravesical BCG therapy. Moreover, intravesical BCG should not be used in patients with active tuberculosis. If persistent fever develops or an acute febrile illness consistent with BCG infection occurs during intravesical BCG therapy, the medication should be permanently discontinued and the patient immediately evaluated and treated for BCG infection. An infectious disease consultation should be sought in determining the appropriate treatment. There are no data to suggest that the acute, local urinary tract toxicity common with intravesical administration of BCG is due to mycobacterial infection, thus antituberculosis drugs should not be used to prevent or treat the local, irritative toxicities of intravesical BCG. References "Product Information. Tice BCG Live (for intravesical use) (BCG)." Organon Pharmaceuticals, West Orange, NJ. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 Durek C, Rusch-Gerdes S, Jocham D, Bohle A "Interference of modern antibacterials with bacillus Calmette-Guerin viability." J Urol 162 (1999): 1959-62 "Product Information. Tice BCG Vaccine (BCG (BCG vaccine))." Organon, West Orange, NJ. Cerner Multum, Inc. "Australian Product Information." O 0 View all 5 references
Professional:CONTRAINDICATED: Antituberculosis drugs may interfere with the anti-tumor activity of intravesical BCG, which contains a live, attenuated strain of Mycobacterium bovis. Available data suggest that intravesical BCG may be sensitive to most antibiotics, particularly those that are routinely used in the treatment of tuberculosis such as streptomycin, para-aminosalicylic acid (PAS), isoniazid (INH), rifampin, and ethambutol. It is reportedly not sensitive to pyrazinamide or cycloserine. Regardless of clinical susceptibility data, however, most antibacterials may still interfere with BCG in the bladder due to their high urinary recovery.
MANAGEMENT: Concomitant use of antituberculosis drugs is considered contraindicated during intravesical BCG therapy. Moreover, intravesical BCG should not be used in patients with active tuberculosis. If persistent fever develops or an acute febrile illness consistent with BCG infection occurs during intravesical BCG therapy, the medication should be permanently discontinued and the patient immediately evaluated and treated for BCG infection. An infectious disease consultation should be sought in determining the appropriate treatment. There are no data to suggest that the acute, local urinary tract toxicity common with intravesical administration of BCG is due to mycobacterial infection, thus antituberculosis drugs should not be used to prevent or treat the local, irritative toxicities of intravesical BCG.
- "Product Information. Tice BCG Live (for intravesical use) (BCG)." Organon Pharmaceuticals, West Orange, NJ.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Durek C, Rusch-Gerdes S, Jocham D, Bohle A "Interference of modern antibacterials with bacillus Calmette-Guerin viability." J Urol 162 (1999): 1959-62
- "Product Information. Tice BCG Vaccine (BCG (BCG vaccine))." Organon, West Orange, NJ.
- Cerner Multum, Inc. "Australian Product Information." O 0
Generic Name: bedaquiline
Brand name: Sirturo
Synonyms: Bedaquiline
Generic Name: bcg
Brand name: TheraCys, Tice BCG, Tice BCG Live, Tice BCG Vaccine, Theracys 3, BCG vaccine
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bedaquiline Fumarate-Theraflu (pseudoephedrine) Cold & Cough
- Bedaquiline Fumarate-Theraflu (pseudoephedrine) Daytime Severe Cold
- Bedaquiline Fumarate-Theraflu Cold and Cough
- Bedaquiline Fumarate-Theraflu Cold and Sore Throat
- Bedaquiline Fumarate-Theraflu Cold/Cough Nighttime
- Bedaquiline Fumarate-Theraflu Daytime Severe Cold
- TheraCys-Bedoz
- TheraCys-BeeGentle Gel
- TheraCys-Beepen-VK
- TheraCys-Bekyree
- TheraCys-Belatacept
- TheraCys-Belatacept Intravenous